[go: up one dir, main page]

NO20053111D0 - Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. - Google Patents

Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.

Info

Publication number
NO20053111D0
NO20053111D0 NO20053111A NO20053111A NO20053111D0 NO 20053111 D0 NO20053111 D0 NO 20053111D0 NO 20053111 A NO20053111 A NO 20053111A NO 20053111 A NO20053111 A NO 20053111A NO 20053111 D0 NO20053111 D0 NO 20053111D0
Authority
NO
Norway
Prior art keywords
cell
peptides
inhibit angiogenesis
invasion
migration
Prior art date
Application number
NO20053111A
Other languages
English (en)
Other versions
NO20053111L (no
Inventor
Robert J Ternansky
Andrew Mazar
Patricia L Gladstone
Amy L Allan
Sean M O'hare
Fernando Donate
Marian Plunkett
Stephanie A Hopkins
Won Hyung Yoon
Graham Parry
Original Assignee
Attenuon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attenuon Llc filed Critical Attenuon Llc
Publication of NO20053111D0 publication Critical patent/NO20053111D0/no
Publication of NO20053111L publication Critical patent/NO20053111L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20053111A 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. NO20053111L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02
PCT/US2003/038175 WO2004047771A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Publications (2)

Publication Number Publication Date
NO20053111D0 true NO20053111D0 (no) 2005-06-24
NO20053111L NO20053111L (no) 2005-08-24

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.
NO20053111A NO20053111L (no) 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.

Country Status (14)

Country Link
US (2) US20050020810A1 (no)
EP (2) EP1569678A4 (no)
JP (2) JP2006514116A (no)
KR (2) KR20050097494A (no)
AU (2) AU2003298726A1 (no)
BR (2) BR0316523A (no)
CA (2) CA2506813A1 (no)
EA (2) EA200500871A1 (no)
HR (2) HRP20050585A2 (no)
MX (2) MXPA05005469A (no)
NO (2) NO20053112L (no)
NZ (2) NZ540889A (no)
PL (2) PL377763A1 (no)
WO (2) WO2004063213A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003298726A1 (en) * 2002-11-25 2004-08-10 Attenuon Llc Peptides which target tumor and endothelial cells, compositions and uses thereof
US20050260557A1 (en) * 2004-05-21 2005-11-24 Mary Zacour Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
US20080261892A1 (en) 2005-02-01 2008-10-23 Ternansky Robert J Acid Addition Salts of Ac-Phscn-Nh2
JP2008528630A (ja) * 2005-02-01 2008-07-31 アテニュオン，エルエルシー 抗血管新生ｐｈｓｃｎペプチドを含む組成物
CN101541743A (zh) 2006-11-08 2009-09-23 于崇曦 多肽及相关化合物的透皮给药系统
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
DK2427475T3 (da) 2009-05-08 2021-02-01 Techfields Biochem Co Ltd Prodrug-sammensætninger med høj gennemtrængelighed af peptider og peptid-relaterede forbindelser
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
CA2839702C (en) 2011-06-23 2021-04-20 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
WO2013170195A1 (en) * 2012-05-11 2013-11-14 Medicus Biosciences, Llc Biocompatible hydrogel treatments for retinal detachment
JP2015522554A (ja) 2012-06-04 2015-08-06 サンコー・エナジー・インコーポレーテッド パラフィン油及び沈降防止剤を含む製剤
ES2664411T3 (es) 2013-03-15 2018-04-19 Suncor Energy Inc. Composiciones herbicidas
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
EP3194980A4 (en) 2014-09-15 2018-07-04 Board of Regents, The University of Texas System Improved single molecule peptide sequencing
CA3110800A1 (en) 2018-07-12 2020-01-16 Board Of Regents, The University Of Texas System Molecular neighborhood detection by oligonucleotides
AU2019355579A1 (en) 2018-10-05 2021-05-06 Board Of Regents, The University Of Texas System Solid-phase N-terminal peptide capture and release
ES3051057T3 (en) 2019-02-15 2025-12-26 Nutrien Ag Solutions Canada Inc The use of protoporphyrin ix derivatives to improve the health of plants

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
WO1981003330A1 (fr) * 1980-05-13 1981-11-26 Mitsubishi Chem Ind Derives de la cysteine et leur production
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
WO1996028206A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
IL117474A (en) * 1995-03-14 2001-04-30 Siemens Ag Removable precise dosing unit containing inhaled drugs for a hearing aid device
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
WO1998010795A2 (en) * 1996-09-10 1998-03-19 The Burnham Institute Tumor homing molecules, conjugates derived therefrom, and methods of using same
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
EP0897911B9 (en) * 1997-01-14 2004-12-01 Kaneka Corporation Process for producing cysteine derivatives
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
DE69839844D1 (de) * 1997-09-10 2008-09-18 Burnham Inst Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
AU5671099A (en) * 1998-08-14 2000-03-06 The Administrators Of The Tulane Eductional Fund Compounds having growth hormone releasing activity
CA2435320C (en) 2001-01-18 2008-06-03 The Regents Of The University Of Michigan Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
AU2003298726A1 (en) * 2002-11-25 2004-08-10 Attenuon Llc Peptides which target tumor and endothelial cells, compositions and uses thereof

Also Published As

Publication number Publication date
US20040162239A1 (en) 2004-08-19
CA2506813A1 (en) 2004-07-29
AU2003298726A1 (en) 2004-08-10
CA2507045A1 (en) 2004-06-10
HRP20050584A2 (hr) 2006-04-30
WO2004047771A2 (en) 2004-06-10
PL377763A1 (pl) 2006-02-20
HRP20050585A2 (en) 2006-02-28
WO2004047771A3 (en) 2005-09-15
NO20053112D0 (no) 2005-06-24
NZ540363A (en) 2007-11-30
PL377701A1 (pl) 2006-02-06
US20050020810A1 (en) 2005-01-27
NO20053112L (no) 2005-08-05
MXPA05005469A (es) 2005-09-08
EA200500871A1 (ru) 2006-04-28
EA200500870A1 (ru) 2006-04-28
JP2006515866A (ja) 2006-06-08
JP2006514116A (ja) 2006-04-27
AU2003297609A1 (en) 2004-06-18
KR20050096917A (ko) 2005-10-06
EP1594521A2 (en) 2005-11-16
NO20053111L (no) 2005-08-24
KR20050097494A (ko) 2005-10-07
BR0316550A (pt) 2005-10-04
BR0316523A (pt) 2005-10-18
WO2004063213A3 (en) 2005-03-03
US7517855B2 (en) 2009-04-14
WO2004063213A2 (en) 2004-07-29
MXPA05005545A (es) 2005-10-18
EP1594521A4 (en) 2008-01-09
NZ540889A (en) 2008-09-26
EP1569678A2 (en) 2005-09-07
EP1569678A4 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
NO20053111D0 (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
PT1398322E (pt) Polipeptidos hasilados, especialmente eritropoietina hasilada
NO20044662L (no) Forbindelser, blandinger og fremgangsmater
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
ITTO20020934A1 (it) Lavastoviglie e relativo procedimento di controllo.
NO20052422D0 (no) Stabiliserte, fast tilstand polypeptidpartikler.
NO20052248D0 (no) Svivelstykkesystem.
EG23477A (en) Contact structure.
NO20023290D0 (no) Konstruksjon til lasting og lossing, samt anvendelse derav
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
NO20052979D0 (no) Propargyl-trifluormetoksy-amino-benzotiazolderivater.
ITPR20020006A1 (it) Struttura prefabbricata, in particolare per edilizia, e procedimento di realizzazione.
ES1052590Y (es) Quiosco-consigna.
ES1052668Y (es) Proteccion segura.
HK1084332A (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
ITRM20020216A1 (it) Interruttore di manovra-sezionatore.
AU2376P (en) August Fire Prunus persica var. nucipersica
NL1020380A1 (nl) Laadinrichting.
ITRM20020505A1 (it) Pasta ipersalina.
ITTO20021130A1 (it) Conduttore trasporto ctc.
ES1052938Y (es) Cantonera.
ES1052011Y (es) Espetero.
ES1052029Y (es) Balin-proyectil.
ES1051703Y (es) Potera.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application